Pharsight

Drugs that contain Naproxen Sodium; Sumatriptan Succinate

1. Treximet patents expiration

TREXIMET Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7332183 CURRAX Multilayer dosage forms containing NSAIDs and triptans
Oct, 2025

(1 year, 7 months from now)

US7332183

(Pediatric)

CURRAX Multilayer dosage forms containing NSAIDs and triptans
Apr, 2026

(2 years from now)

Market Authorisation Date: 15 April, 2008

Treatment: Treatment of migraine; Acute treatment of migraine

Dosage: TABLET;ORAL

How can I launch a generic of TREXIMET before it's drug patent expiration?
More Information on Dosage

TREXIMET family patents

Family Patents